Sleep Apnea Devices Market - By Product, By End-use & Global Forecast, 2023

Description

List of Tables

Sleep Apnea Devices industry will depict positive trajectory through 2032 owing to the increasing prevalence of sleep disorders and related co-morbidities. According to credible reports, around 22 million Americans have sleep apnea. The growing senior population prone to sleep apnea and related health conditions have bolstered the demand for sleep disorders diagnosis & treatment equipment.

The most recent method of treating obstructive sleep apnea is the Inspire system. Inspire attempts to treat the root of sleep apnea, not just the symptoms, by activating the tongue and airway muscles. Such developmental trends around sleep apnea are likely to offer lucrative opportunities to the market expansion in the coming years.

Overall, the sleep apnea devices industry is segmented in terms of product, end-use and region.

Based on the product, the diagnostics segment will grow rapidly through 2032 due to the increasing demand for sleep apnea devices for sleep disease diagnosis and rising awareness regarding the benefits of advanced diagnostic sleep apnea devices. Constant technological innovations in the field of sleep apnea devices is enhancing its use globally. These devices offer multiple advantages in monitoring sleep cycles using a non-invasive method and providing a graphical summary of sleep patterns over time.

By end-use, the sleep laboratories & hospitals segment will demonstrate sturdy growth by 2032 end, owing to the increasing preference of patients towards sleep laboratories & hospitals for quality sleep disorders treatment and affordability. In addition, sleep laboratories & hospitals offer an accurate diagnosis that empower precise & effective treatment, thus delivering optimal treatment outcomes along with affordability.

Regionally, the Asia Pacific sleep apnea devices industry is estimated to garner notable gains during 2023-2032. The regional market growth will come from the mounting demand for early diagnosis of sleep apnea, mainly due to the rising prevalence of sleep apnea. As per a study on Obstructive Sleep Apnea Hypopnea Syndrome, the OSA prevalence ranges from 4.4% to 13.7% in the Indian subcontinent.

Besides, the increasing number of key participants entering the market, along with favorable government initiatives and well-developed healthcare infrastructure, will favor the regional outlook. The surging geriatric population base in the Asia Pacific region is anticipated to push the business growth, further amplifying the market expansion in the coming years.

Product Code: 489

Chapter 1 Methodology & Scope

1.1 Industry coverage
1.2 Market scope & definitions
1.3 Base estimates & working
- 1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data sources
- 1.7.1 Primary
- 1.7.2 Secondary
  - 1.7.2.1 Paid sources
  - 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 Sleep apnea devices industry 360 degree synopsis, 2018 - 2032
- 2.1.1 Business trends
- 2.1.2 Product trends
- 2.1.3 End-use trends
- 2.1.4 Regional trends

Chapter 3 Sleep Apnea Devices Industry Insights

3.1 Industry landscape, 2018 - 2032
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Growing prevalence of sleep apnea and related co-morbidities
  - 3.2.1.2 Rising demand for portable, efficient and superior sleep apnea devices
  - 3.2.1.3 Insurance coverage for treatment of sleep apnea and other sleep disorders
  - 3.2.1.4 Growing awareness regarding sleep apnea and other sleep disorders
  - 3.2.1.5 Increasing aging population
  - 3.2.1.6 Product innovation strategy adopted by key industry players
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Clinical consequences and economic impact of sleep apnea and related sleep disorders
  - 3.2.2.2 Lack of adherence to sleep apnea treatment
3.3 Growth potential analysis
- 3.3.1 By product
- 3.3.2 By end-use
3.4 COVID-19 impact analysis
3.5 Technology landscape
3.6 Future market trends
3.7 Gap analysis
3.8 Regulatory landscape
- 3.8.1 U.S.
- 3.8.2 Europe
3.9 Reimbursement scenario
3.10 Porter's analysis
3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2021

4.1 Introduction
4.2 Company matrix analysis, 2021
4.3 Strategy dashboard, 2021

Chapter 5 Sleep Apnea Devices Market, By Product

5.1 Key product trends
5.2 Therapeutics
- 5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 5.2.2 Airway clearance system
  - 5.2.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 5.2.3 Adaptive servo-ventilation (ASV)
  - 5.2.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 5.2.4 Positive airway pressure (PAP) devices
  - 5.2.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 5.2.5 Oral appliances
  - 5.2.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 5.2.6 Oxygen devices
  - 5.2.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 5.2.7 Others
  - 5.2.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3 Diagnostics
- 5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 5.3.2 Actigraphy systems
  - 5.3.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 5.3.3 Polysomnography (PSG) device
  - 5.3.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 5.3.4 Respiratory polygraph
  - 5.3.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 5.3.5 Sleep screening devices
  - 5.3.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 6 Sleep Apnea Devices Market, By End-use

6.1 Key end-use trends
6.2 Home care settings & individuals
- 6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3 Sleep laboratories & hospitals
- 6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7 Sleep Apnea Devices Market Market, By Region

7.1 Key regional trends
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 Italy
- 7.3.4 France
- 7.3.5 Spain
- 7.3.6 Poland
- 7.3.7 Netherlands
- 7.3.8 Sweden
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
- 7.4.6 Indonesia
- 7.4.7 Thailand
- 7.4.8 Philippines
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
- 7.5.4 Columbia
- 7.5.5 Chile
- 7.5.6 Peru
7.6 Middle East & Africa
- 7.6.1 South Africa
- 7.6.2 Saudi Arabia
- 7.6.3 UAE
- 7.6.4 Egypt
- 7.6.5 Nigeria
- 7.6.6 Israel

Chapter 8 Company Profiles

8.1 BMC Medical Co., Ltd.
8.2 Cadwell Laboratories Inc.
8.3 LivaNova PLC
8.4 Fisher & Paykel Healthcare
8.5 Invacare Corporation (Asahi Kasei)
8.6 Itamar Medical Ltd
8.7 Natus Medical Inc.
8.8 Nihon Kohden
8.9 Koninklijke Philips N.V.
8.10 ResMed Inc.
8.11 Teleflex Inc.
8.12 Drive DeVilbiss International (Drive Medical)
8.13 WEINMANN Emergency Medical Technology GmbH + Co. KG